These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7524123)

  • 1. [Current aspects of hepatitis C].
    Henry JP; Hayard P; Hayani A; Ligny G
    Rev Med Brux; 1994; 15(4):211-5. PubMed ID: 7524123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis C].
    Camps Bansell J; Mur RE
    Enferm Infecc Microbiol Clin; 1995 Apr; 13 Suppl 1():31-9. PubMed ID: 7772621
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

  • 8. [HCV infection in autoimmune hepatitis].
    Komeda T; Fukuda Y; Imoto S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):871-6. PubMed ID: 7563893
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C.
    Willems M; Moshage H; Fevery J; Yap SH
    Neth J Med; 1992 Aug; 41(1-2):36-43. PubMed ID: 1383840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular methods of hepatitis C genotyping.
    Weck K
    Expert Rev Mol Diagn; 2005 Jul; 5(4):507-20. PubMed ID: 16013969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C].
    Gattoni A; Cecere A; Caiazzo R; Romano C
    Clin Ter; 1996 Sep; 147(9):413-38. PubMed ID: 9102232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
    Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
    Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral hepatitis C].
    Garassini MA; Alvarado MC
    G E N; 1993; 47(4):257-73. PubMed ID: 7519574
    [No Abstract]   [Full Text] [Related]  

  • 16. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IFN in the treatment of chronic viral hepatitis. Efficacy and tolerance of lymphoblastoid alpha interferon in HIV-negative drug addicts and associated chronic active hepatitis C].
    Acone N; B1ll'Aquila G; Magliocca M; Nigro FS; Pacifico P; Imparato L
    Clin Ter; 1994 Nov; 145(11):369-72. PubMed ID: 7534222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of hepatitis C following liver transplantation: treatment with interferon.
    Van Thiel DH; Fagiuoli S; Caraceni P; Nadir A; Wright HI
    Transplant Sci; 1994 Dec; 4 Suppl 1():S26-8. PubMed ID: 7542986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.